A patient audit of more than 1,000 lupus nephritis charts highlights growing experience with biologics and calcineurin inhibitors, alongside rising off-label adoption of SGLT2 inhibitors. A patient audit of more than 1,000 lupus nephritis charts highlights gr…
Exton, PA, March 06, 2026 (GLOBE NEWSWIRE) -- New findings from Spherix Global Insights Patient Chart Dynamix: Lupus Nephritis (US), 2025 report reveal a treatment landscape in transition as speciali… [+8287 chars]
